These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18632222)

  • 1. Loss of heterozygosity in the RAD51 and BRCA2 regions in breast cancer.
    Nowacka-Zawisza M; Bryś M; Romanowicz-Makowska H; Kulig A; Krajewska WM
    Cancer Detect Prev; 2008; 32(2):144-8. PubMed ID: 18632222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.
    Gonzalez R; Silva JM; Dominguez G; Garcia JM; Martinez G; Vargas J; Provencio M; España P; Bonilla F
    Br J Cancer; 1999 Oct; 81(3):503-9. PubMed ID: 10507777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dinucleotide repeat polymorphisms of RAD51, BRCA1, BRCA2 gene regions in breast cancer.
    Nowacka-Zawisza M; Brys M; Romanowicz-Makowska H; Kulig A; Krajewska WM
    Pathol Int; 2008 May; 58(5):275-81. PubMed ID: 18429825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity for chromosomal regions 15q14-21.1, 17q21.31, and 13q12.3-13.1 and its relevance for prostate cancer.
    Nowacka-Zawisza M; Forma E; Walczak M; Różański W; Bryś M; Krajewska WM
    Med Oncol; 2015 Nov; 32(11):246. PubMed ID: 26433958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic instability in the RAD51 and BRCA1 regions in breast cancer.
    Nowacka-Zawisza M; Bryś M; Romanowicz-Makowska H; Kulig A; Krajewska WM
    Cell Mol Biol Lett; 2007; 12(2):192-205. PubMed ID: 17180310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity in BRCA1 and BRCA2 markers and high-grade malignancy in breast cancer.
    Silva JM; Gonzalez R; Provencio M; Dominguez G; Garcia JM; Gallego I; Palacios J; España P; Bonilla F
    Breast Cancer Res Treat; 1999 Jan; 53(1):9-17. PubMed ID: 10206068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of BRCA2 correlates with reduced long-term survival of sporadic breast cancer patients.
    Hampl JA; Hampl M; Reiss G; Koch R; Saeger HD; Schackert HK
    Anticancer Res; 2004; 24(1):281-90. PubMed ID: 15015609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant allelic loss of ANX7region (10q21) in hormone receptor negative breast carcinomas.
    Leighton X; Srikantan V; Pollard HB; Sukumar S; Srivastava M
    Cancer Lett; 2004 Jul; 210(2):239-44. PubMed ID: 15183540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
    Oldenburg RA; Kroeze-Jansema K; Meijers-Heijboer H; van Asperen CJ; Hoogerbrugge N; van Leeuwen I; Vasen HF; Cleton-Jansen AM; Kraan J; Houwing-Duistermaat JJ; Morreau H; Cornelisse CJ; Devilee P
    Clin Cancer Res; 2006 Mar; 12(6):1693-700. PubMed ID: 16551851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Loss of heterozygosity on chromosome 3p in breast cancer and precancerous lesion].
    Tang XL; Yao GY; Chen LR; Yang ZR; Li SL
    Zhonghua Wai Ke Za Zhi; 2006 Oct; 44(19):1314-7. PubMed ID: 17217815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity and microsatellite instability at RAD52 and RAD54 loci in breast cancer.
    Nowacka-Zawisza M; Bryś M; Hanna RM; Zadrozny M; Kulig A; Krajewska WM
    Pol J Pathol; 2006; 57(2):83-9. PubMed ID: 17019970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The BRCA1/BRCA2/Rad51 complex is a prognostic and predictive factor in early breast cancer.
    Söderlund K; Skoog L; Fornander T; Askmalm MS
    Radiother Oncol; 2007 Sep; 84(3):242-51. PubMed ID: 17707537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity at 17p13.3-ter, distal to TP53, correlates with negative hormonal phenotype in sporadic breast cancer.
    Roncuzzi L; Brognara I; Baiocchi D; Amadori D; Gasperi-Campani A
    Oncol Rep; 2005 Aug; 14(2):471-4. PubMed ID: 16012732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsatellite instability correlates with negative expression of estrogen and progesterone receptors in sporadic breast cancer.
    Caldés T; Perez-Segura P; Tosar A; de La Hoya M; Diaz-Rubio E
    Teratog Carcinog Mutagen; 2000; 20(5):283-91. PubMed ID: 10992275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association of polymorphisms of N372H in BRCA2 gene and 135G/C in RAD51 gene and breast cancers].
    Hu R; Wei Y; Jiang WJ; Yao WX; Long QM; Zhang JH; Liang Y; Tang XL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Nov; 39(6):973-5. PubMed ID: 19253839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: correlation with proliferative activity, ploidy and hormonal status of the tumors.
    Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Koutroumbi E; Markopoulos C; Gogas J; Kittas C
    Anticancer Res; 2001; 21(2A):991-9. PubMed ID: 11396193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution 19p13.2-13.3 allelotyping of breast carcinomas demonstrates frequent loss of heterozygosity.
    Yang TL; Su YR; Huang CS; Yu JC; Lo YL; Wu PE; Shen CY
    Genes Chromosomes Cancer; 2004 Nov; 41(3):250-6. PubMed ID: 15334548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic analysis of the BRCA2 tumor suppressor gene region in cutaneous squamous cell carcinomas.
    Gray SE; Kay E; Leader M; Mabruk M
    J Cutan Pathol; 2008 Jan; 35(1):1-9. PubMed ID: 18095987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association between LOH in the 9p region and clinicopathologic parameters in primary breast cancer.
    Vieira de Oliveira SF; Oliveira MM; Urban CA; de Lima RS; Cavalli IJ; Ribeiro EM
    Cancer Genet Cytogenet; 2010 Jul; 200(1):23-7. PubMed ID: 20513530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of somatic missense mutation of BRCA2 in female breast cancer from Taiwan.
    Chen FM; Hou MF; Chang MY; Wang JY; Hsieh JS; Ou-Yang F; Huang TJ; Lin SR
    Cancer Lett; 2005 Apr; 220(2):177-84. PubMed ID: 15766593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.